Asan Medical Center-Department of Oncology ( Site 4901)
Asan Medical Center-Department of Oncology ( Site 4901)
Seoul, South Korea1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Plus Enfortumab Vedotin (EV) With and Without Pembrolizumab in Advanced Urothelial Carcinoma (MK-3475-04C/KEYMAKER-U04) | Neoplasms by Histologic Type, autosomal dominant Parkinson disease 4, carcinoma, epithelial neoplasm, neoplasm, transitional cell carcinoma | Active, not recruiting | Phase 1 / Phase 2 | 2026-02-18 | NCT06483334 |